Wenya Su
- Biomaterials top 5%
- Molecular Biology
- Biomedical Engineering
- Materials Chemistry
- Pharmaceutical Science top 5%
- Topics
- Nanoparticle-Based Drug Delivery (7 papers)Antibiotic Resistance in Bacteria (5 papers)Anorectal Disease Treatments and Outcomes (4 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Wenya Su
27 papers receiving 580 citations
Peers
Comparison fields: 5 of 81
- Biomaterials 281
- Molecular Biology 267
- Biomedical Engineering 208
- Materials Chemistry 100
- Pharmaceutical Science 75
Countries citing papers authored by Wenya Su
This map shows the geographic impact of Wenya Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenya Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenya Su more than expected).
Fields of papers citing papers by Wenya Su
This network shows the impact of papers produced by Wenya Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenya Su. The network helps show where Wenya Su may publish in the future.
Co-authorship network of co-authors of Wenya Su
This figure shows the co-authorship network connecting the top 25 collaborators of Wenya Su. A scholar is included among the top collaborators of Wenya Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenya Su. Wenya Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 2 | |
| 7 | 5 | |
| 8 | 4 | |
| 9 | 12 | |
| 10 | 11 | |
| 11 | 1 | |
| 12 | 45 | |
| 13 | 8 | |
| 14 | 12 | |
| 15 | 14 | |
| 16 | 39 | |
| 17 | 50 | |
| 18 | 48 | |
| 19 | 33 | |
| 20 | 171 |
About Wenya Su
Wenya Su is a scholar working on Molecular Medicine, Biomaterials and Endocrinology, having authored 28 papers that have together received 592 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (7 papers), Antibiotic Resistance in Bacteria (5 papers) and Anorectal Disease Treatments and Outcomes (4 papers). The work is most often cited by research in Biomaterials (281 citations), Pharmaceutical Science (75 citations) and Molecular Medicine (28 citations). Wenya Su has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Jin Chang, Hanjie Wang, Zhenyu Liao, Sheng Wang, Peiqi Zhao, Ruifang Niu, Lei Han, Wei Li, Qin Li and Cui Ye. Their work appears in journals such as Biomaterials, Advanced Functional Materials and Langmuir.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.